The Club of Rome set forth on a global depopulation plan based on biowarfare.
These “keys,” GP120/GP41, on the viral “spike protein” allow for viral entry and infection. We decided to “follow the keys” and find out who held the patents. Why? If you can chemically “block” these “keys” from working using pharmaceuticals you can prevent infection. The patent holders themselves would be in-bed with pharmaceutical giants trying to develop drugs or vaccines that target these “keys” and making millions on their patent!
So… who holds the patent for the GP120 glycoprotein on the S1 spike protein region? Dr. Anthony Fauci holds the patent to GP120 on the S1 region of the spike protein that will recognize and bind to receptors on the host cell. This starts the process by which the virus can then fuse its viral membrane with the host cell membrane to enter the cell; in other words it will then activate GP41 on the S2 region of the spike protein.
Who then holds the patent for the GP41 “key” on the S2 region of the spike protein? Joseph Cotropia of Bioclonetics Inc. (Now Enzolytics Inc.) holds the patent to GP41 and the monoclonal antibodies that can “irreversibly block” the Glycoprotein GP41 which would stop viral membrane fusion and thus infection. It’s called the Monoclonal Antibody Clone 3 which is the cure for HIV, SARS-CoV-2 and several Cancer.
Why is GP41 important? GP41 is a stable Glycoprotein and unlike GP120 it does not mutate. If one uses GP41 to manufacture “spike proteins” through “Gain-of-Function” experiments you now have a stable site that can be targeted by pharmaceuticals drugs or vaccines! Basically any pathogen that has GP41 can be inactivated and that includes HIV-1, SARS-CoV-2 and other viruses that cause Cancers! Did you think the NWO would release a bioweapon without a built-in back door to turn it off?
Here’s the BOOM! What’s curious about Joseph Cotropias’ monoclonal antibody “Clone 3” research is that it was once funded by Fauci’s NIH and this company has sat on the “cure” since 1989; thirty two years while million of AIDS, Cancer and now SARS-COV-2 patients perished and big pharma made trillions pushing their poisons meantime taxpayers funded their research, foundations, drugs and vaccines! The real question is whether or not NIH had the cure prior to the 1976 Small Pox/1978 Hepatitis B vaccines that were tainted with HIV and infected two thirds of the African continent and millions in the USA? What we do know is that key NIH players are now joining Enzolytics such as Dr. Ronald Moss who was recently appointed to the Enzolytics Medical Advisory Board. He has also worked closely with the NIH, FDA, CDC and the WHO!
Here’s the BOOM… BOOM! On March 22, 2021 Enzolytics filed for an NIH grant seeking funding for its production of monoclonal antibodies (Clone 3) targeting sites on both the HIV-1 and SARS-Cov-2 virus using the “recent” discovery of “conserved sites.” These “conserved sites” have identical sequences of DNA or RNA that occur in different species over generations and have evolved unchanged over generations; 8 conserved sites on the HIV-1 virus and 11 sites on the Coronavirus have been identified using artificial intelligence techniques that analyzed 87,336 HIV variants and 50,512 variants of the Coronavirus. What does this all mean? Conserved or genetically unchanged sites are targets for a potential drug cure! A cure for all HIV variants and Coronavirus variants!
“A review of the HIV data reported to the Los Alamos HIV Clinical Database (August 2010), reveals that CLONE 3 antibody has the capacity to neutralize 2184 of 2229 (or 98%) of HIV strains identified in the 7 regions of the world.”
BioClonetics goes on to say: “The neutralizing capacity of CLONE 3 has been established in tests conducted by five independent research groups. Research conducted at the University of South Florida was funded by a six year $1.4 million USD NIH grant. The National Institute of Health (NlH) studies, conducted by Anthony Fauci and published in Nature Medicine November 2001, provide further validation of the efficacy of this linear amino acid epitope, KLIC (Clone 3) as a protective active vaccine immunogen.”
“CLONE 3 Antibody was discovered and delineated in spring of 1989 and published in BioClonetics’ first patent specifications that had a priority date of August 24, 1989.”
1989—that’s thirty two years ago. So, if CLONE 3 looked good to Fauci so early in the AIDS epidemic, and if it worked against a whopping ninety-eight percent of HIV strains, why then has it been shelved by our government? Is Big Pharma making so much money from AIDS drugs that the government itself has turned a blind eye?
Here’s the BOOM… BOOM… BOOM! Bioclonetics Inc. that developed the “cure” called Monoclonal Antibody “Clone 3” has merged with Immunotech Inc. that developed the “prophylactic” called ITV-1 made from Inactivated Pepsin Fragments (IPF) both now under the Enzolytics umbrella! And Enzyolics Inc. has now partnered with Intel Corporation! Both the prophylactic and the cure are now in the hands of the NWO… and we’re certain the “chip” is inside!
Backstory: Here’s the backstory of the development of the “prophylactic” called ITV-1 consisting of Inactivated Pepsin Fragment (IPF) also produced by Enzolytics Inc. And although ITV-1 is not a vaccine it is being promoted as one. Furthermore, it was approved by the FDA as a nutraceutical! How does ITV-1 work? You will recall that the “spike protein” has a “furin cleavage site” where the host cell’s “furin protein” binds and cleaves to activate viral entry into the cell leading to infection. The “furin protein” is a protease protein with a similar structure to pepsin!
ITV-1 containing “Inactivated Pepsin Fragments” will bind to the furin cleavage site on the spike protein BLOCKING the host cell furin protein from binding. This binding is irreversible preventing viral infection! However, the company also states that it binds to GP120/GP41 preventing viral attachment and can help to regenerate new WBC of the immune system.
Odd thing though… this report was written in 2014? How did they know all of this?
Alternate names for ITV-1: Immune therapeutic vaccine-1; ImmunH; Inactivated pepsin fraction HIV vaccine; IPF-ITV Phases; IPF-ITV-1; Irreversible pepsin fraction HIV vaccine; ITV-1. The trade names for ITV-1 include ImmunaZin and Enzoimmune Active; both not available in North America, however Enzoimmune Active is available only in Europe. Apparently it is taken as a spray in the mouth for a few weeks. Here is the online site for ordering the prophylactic ITV-1. Unfortunately they are leaving the Canada & U.S.A. out to dry and only supplying members of the Islamic State! The Club of Rome is successfully carrying out their covert objectives: depopulation followed by the Islamization of the planet! AL Akbar Sheeple!
ImmunaZin and Enzoimmune Active! COVID/HIV/Cancer Prophylactic/Therapeutic Exists!… But we need a chemist…
Here are the Timeline of Events:
- August 24, 1989: Joseph Cotropia files patent for Bioclonetics Inc. (Monoclonal Antibody Clone 3). (link)
- November 12, 2004: Harry Zhabilov (Zhabilov Trust) files patent for Inactivated pepsin fragments (IPF) for modulating immune system activity against human malignant tumor cells. (link)
- January 30, 2009: Immunotech Laboratories Inc. entered into a licensing agreement with Harry Zhabilov (Zhabilov Trust) for use of the patents underlying use of IPF (ITV-1) in treatment of HIV/AIDS. The original patent holder of the IPF (Inactivated Pepsin Fragments). (link)
- April 16, 2020: Enzolytics announces it holds 49% of Immunotech Laboratories BG that produces ITV-1 (Immune Therapeutic Vaccine-1) a suspension of Inactivated Pepsin Fraction (IPF). (link)
- December 1, 2020: Enzolytics (produces ITV-1) completes a merger with Bioclonetics Inc. (Monoclonal Antibody Clone 3). (link)
- March 22, 2021: Enzolytics announces the filing of an NIH grant to test Clone 3. (link)
- May 17, 2021: Enzolytics Inc. and Intel Corporation partner to Co-Author White Paper on Use of Artificial Intelligence for Social Good. (link)
- June 7, 2021: Enzolytics Announces A Comprehensive Therapeutic Protocol For Production Of Monoclonal Antibodies To Address Ongoing And Future Pandemics. (link)
- September 6, 2021: Enzolytics, Inc. Announces Execution of Letter of Intent with BioClonetics Immunotherapeutics, Inc. (link)
- October 7, 2021: Enzolytics Inc. and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapy (link)
Intel Corporation is Your New Master!
On May 17, 2021 Enzolytics Inc. & Intel Corporation partnered to Co-Author a white paper on the use of Artificial Intelligence for social good titled, “Optimizing Empathetic A.I. to Cure Deadly Diseases. ” It is about computer-driven AI to control mankind! The NWO now have in their possession both the “prophylactic” and the “cure!” Meet your NWO Master; Intel is the “Great Reset!”